alexa GABAA Agonists and NMDA Antagonists have a Therapeutic and Prophylactic Effect in Alzheimer's and Parkinson's Disease

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

GABAA Agonists and NMDA Antagonists have a Therapeutic and Prophylactic Effect in Alzheimer's and Parkinson's Disease

Alzheimer’s and Parkinson’s diseases are neurodegenerative diseases which cannot be healed so far. In both diseases, a GABAergic-glutaminergic neurotransmitter inequality might occur. Neural networks are advised for Parkinson’s disease in the extrapyramidal system and for Alzheimer’s disease in the hippocampus and the temporal cortex.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger